Reply by Authors

Patrick O Richard¹, Shaheena Bashir², Bruno D Riverin¹, Shabbir M H Alibhai³, S Joseph Kim^{4

5}, Ardalan Ahmad⁶, Neil E Fleshner⁶, Amit Gupta^{3

7}, Aza Mohammed⁸, Alexandre R Zlotta^{6

9}, Girish S Kulkarni^{6

5}

Affiliations

¹ Division of Urology, Departments of Surgery, Centre Hospitalier Universitaire de Sherbrooke and Centre de Recherche du CHUS , Sherbrooke , Quebec , Canada.
² Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network , Toronto , Ontario , Canada.
³ Department of Medicine, University Health Network and University of Toronto , Toronto , Ontario , Canada.
⁴ Division of Nephrology and Kidney Transplant Program, Toronto General Hospital, University Health Network and University of Toronto , Toronto , Ontario , Canada.
⁵ Institute for Clinical Evaluative Sciences , Toronto , Ontario , Canada.
⁶ Division of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto , Ontario , Canada.
⁷ Department of Urology, Cedars-Sinai Medical Center , Los Angeles , California.
⁸ Department of Urology, Luton and Dunstable Hospital National Health Service Foundation Trust , Luton , United Kingdom.
⁹ Division of Urology, Departments of Surgery, Mount Sinai Hospital and University of Toronto , Toronto , Ontario , Canada.

Comment

Patrick O Richard et al. J Urol. 2019 Aug.

. 2019 Aug;202(2):325.

doi: 10.1097/01.JU.0000558494.56102.db. Epub 2019 Jul 8.

¹ Division of Urology, Departments of Surgery, Centre Hospitalier Universitaire de Sherbrooke and Centre de Recherche du CHUS , Sherbrooke , Quebec , Canada.
² Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network , Toronto , Ontario , Canada.
³ Department of Medicine, University Health Network and University of Toronto , Toronto , Ontario , Canada.
⁴ Division of Nephrology and Kidney Transplant Program, Toronto General Hospital, University Health Network and University of Toronto , Toronto , Ontario , Canada.
⁵ Institute for Clinical Evaluative Sciences , Toronto , Ontario , Canada.
⁶ Division of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto , Ontario , Canada.
⁷ Department of Urology, Cedars-Sinai Medical Center , Los Angeles , California.
⁸ Department of Urology, Luton and Dunstable Hospital National Health Service Foundation Trust , Luton , United Kingdom.
⁹ Division of Urology, Departments of Surgery, Mount Sinai Hospital and University of Toronto , Toronto , Ontario , Canada.

No abstract available

Comment on

Editorial Comment.
Jarosek S, Elliott S. Jarosek S, et al. J Urol. 2019 Aug;202(2):324. doi: 10.1097/01.JU.0000558492.10361.36. Epub 2019 Jul 8. J Urol. 2019. PMID: 31042131 No abstract available.
Editorial Comment.
Izard JP, Siemens DR. Izard JP, et al. J Urol. 2019 Aug;202(2):324-325. doi: 10.1097/01.JU.0000558493.48479.98. Epub 2019 Jul 8. J Urol. 2019. PMID: 31042133 No abstract available.